Charles River Laboratories International, Inc. (CRL)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 230.09 |
| Open | 228.02 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 223.49 - 233.72 |
| 52-week range | 161.65 - 275.00 |
| Volume | |
| Avg. volume | 530,780 |
| Market cap | 11.721B |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | 24.68 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
WILMINGTON, Mass., April 16, 2024--Charles River launches the Alternative Methods Advancement Project (AMAP), an initiative to develop alternatives to reduce animal testing.
- Business Wire
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
WILMINGTON, Mass., April 12, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 9th, at 8:30 a.m. ET.
- Business Wire
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
WILMINGTON, Mass. & DUBLIN, April 11, 2024--Charles River and Deciphex launch Patholytix Foresight, an AI-powered decision support tool for toxicologic pathology.
© 2024 Yahoo. All rights reserved.